S. Hadler

发表

W. Williams, F. Averhoff, S. Hadler, 1997, American family physician.

Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team.

John W. Glasser, J P Mullooly, R. Davis, 1997, Pediatrics.

The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine. A postmarketing assessment.

S. Rosenthal, S. Hadler, R. Chen, 1996, Archives of pediatrics & adolescent medicine.

Widespread paralytic poliomyelitis in Pakistan: A case-control study to determine risk factors and implications for poliomyelitis eradication.

R. Sutter, H. Jafari, S. Hadler, 2000, The Journal of infectious diseases.

Defining Surrogate Serologic Tests with Respect to Predicting Protective Vaccine Efficacy: Poliovirus Vaccination

L. Sawyer, M. Pallansch, R. Sutter, 1995, Annals of the New York Academy of Sciences.

Therapy for children with invasive pneumococcal infections

B. Schwartz, R. Breiman, R. Jacobs, 1997 .

Acellular pertussis vaccine: recommendations for use as the initial series in infants and children. American Academy of Pediatrics Committee on Infectious Diseases.

B. Schwartz, R. Breiman, R. Jacobs, 1997, Pediatrics.

Simultaneous administration of childhood vaccines: an important public health policy that is safe and efficacious.

G. E. King, S. Hadler, G. King, 1994, The Pediatric infectious disease journal.

Pertussis control: time for something new?

T. Clark, N. Messonnier, Nancy E. Messonnier, 2012, Trends in microbiology.

Immunoprophylaxis of Viral Diseases

J. Seward, S. Hadler, 2010 .

Reporting efficiency during a measles outbreak in New York City, 1991.

P. Strebel, R. Sutter, L. Markowitz, 1993, American journal of public health.

Trends in vaccine-preventable diseases

M. Wharton, W. Orenstein, S. Hadler, 1997 .

Trends in importation of measles to the United States, 1986-1994.

C. Vitek, S. Redd, S. Redd, 1997, JAMA.

The immunization of children enrolled in the Special Supplemental Food Program for Women, Infants, and Children (WIC). The impact of different strategies.

G. Birkhead, D. Morse, C. Lebaron, 1995, JAMA.

The interruption of transmission of indigenous measles in the United States during 1993.

P. Rhodes, S. Redd, S. Hadler, 1998, The Pediatric infectious disease journal.

Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.

M. Wharton, S. Reef, W. Williams, 1996, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

Measles, Mumps, and Rubella - Vaccine Use and Strategies for Elimination of Measles, Rubella, and Congenital Rubella Syndrome and Control of Mumps: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Vol. 47/No. RR-8.

S. Reef, L. Phillips, C. Dykewicz, 1998 .

Global Epidemiology of Diphtheria, 2000–2017

T. Cherian, A. MacNeil, T. Tiwari, 2019, Emerging infectious diseases.

Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021

J. Gargano, B. Bell, Heather M. Scobie, 2021, MMWR. Morbidity and mortality weekly report.

Varicella in Americans from NHANES III: Implications for control through routine immunization

P. Kilgore, M. Wharton, D. Kruszon-Moran, 2003, Journal of medical virology.

The Epidemiology of Nationally Reported Pertussis in the United States, 2000-2016.

T. Skoff, S. Hariri, S. Hadler, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Tetanus surveillance--United States, 1991-1994.

P. Strebel, M. Wharton, R. Sutter, 1997, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

Tetanus surveillance--United States, 1989-1990.

P. Strebel, R. Sutter, S. Cochi, 1992, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

Risk of chronic arthropathy among women after rubella vaccination. Vaccine Safety Datalink Team.

S. Black, S. Cochi, S. Wassilak, 1997, JAMA.

Cost benefit of combining antigens.

S. Hadler, 1994, Biologicals : journal of the International Association of Biological Standardization.

Immunization of adolescents: recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association.

W. Williams, F. Averhoff, S. Hadler, 1997, The Journal of school health.

The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021

B. Bell, M. Chamberland, M. Daley, 2021, MMWR. Morbidity and mortality weekly report.

Rotavirus vaccines--from licensure to disease reduction.

W. Orenstein, J. Kuritsky, S. Hadler, 1996, The Journal of infectious diseases.

Measles surveillance--United States, 1991.

S. Redd, W. Orenstein, S. Hadler, 1992, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

The geographic distribution of measles in the United States, 1980 through 1989.

B. Hersh, A. Funkhouser, L. Markowitz, 1992, JAMA.

Effectiveness of the pertussis vaccination program as determined by use of the screening method: United States, 1992-1994.

P. Strebel, M. Wharton, B. Bardenheier, 1997, The Journal of infectious diseases.

Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population.

B. McMahon, W. Heyward, A. Lanier, 1989, JAMA.

Pertussis surveillance--United States, 1989-1991.

E. Zell, P. Strebel, S. Cochi, 1992, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

Utility of Large‐linked Databases in Vaccine Safety, Particularly in Distinguishing Independent and Synergistic Effects

Robert T. Chen, John W. Glasser, S. Hadler, 1995, Annals of the New York Academy of Sciences.

Recommendations for use of Haemophilus b conjugate vaccines and a combined diphtheria, tetanus, pertussis, and Haemophilus b vaccine : recommendations of the Advisory Committee on Immunization Practices (ACIP).

R. Sutter, J. Wenger, S. Hadler, 1993 .

Preschool children at high risk for measles: opportunities to vaccinate.

S. Hutchins, S. Hadler, E. Mihalek, 1993, American journal of public health.

Inactivated Poliovirus Vaccine and Vaccine-Associated Paralytic Poliomyelitis-Reply

Mark A. Miller, P. Strebel, R. Sutter, 1997 .

Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule.

P. Strebel, R. Sutter, M A Miller, 1996, JAMA.

P. Strebel, S. Hadler, J. Gindler, 1995, Clinical pediatrics.

Progress Toward Poliomyelitis Eradication--Afghanistan, January 2014‒August 2015.

S. Hadler, R. Tangermann, C. Mbaeyi, 2015, MMWR. Morbidity and mortality weekly report.

Progress Toward Poliomyelitis Eradication - Afghanistan, January 2015‒August 2016.

J. Jorba, S. Hadler, Hemant Shukla, 2016, MMWR. Morbidity and mortality weekly report.

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years — United States, May 2021

J. Gargano, B. Bell, Heather M. Scobie, 2021, MMWR. Morbidity and mortality weekly report.

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021

B. Bell, M. Chamberland, M. Daley, 2021, MMWR. Morbidity and mortality weekly report.

Successes and failures in vaccine delivery: evaluation of the immunization delivery system in Puerto Rico.

J. Rullán, E. Zell, F. Cutts, 1993, Pediatrics.

Hepatitis B vaccination programs for health care personnel in U.S. hospitals.

W. Williams, J. W. White, S. Hadler, 1990, Public health reports.

Effectiveness and Cost-Effectiveness of Linking the Special Supplemental Program for Women, Infants, and Children (WIC) and Immunization Activities

J. Rosenthal, S. Hutchins, S. Hadler, 1999, Journal of public health policy.

Reputed Brain Damage and 'Serious' Reactions From DTP Vaccines-Reply

Robert T. Chen, S. Rosenthal, S. Hadler, 1997 .

Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021

B. Bell, A. Fiore, M. Wharton, 2022, MMWR. Morbidity and mortality weekly report.

Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices — United States, July 2021

E. Woo, K. Ess, M. Wharton, 2021, MMWR. Morbidity and mortality weekly report.

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021

J. Gargano, B. Bell, Heather M. Scobie, 2021, MMWR. Morbidity and mortality weekly report.

The Advisory Committee on Immunization Practices’ Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 Vaccines — United States, February 2022

Sarah A. Meyer, R. Link-Gelles, B. Bell, 2011, MMWR. Morbidity and mortality weekly report.

Pertussis vaccination : use of acellular pertussis vaccines among infants and young children : recommendations of the Advisory Committee on Immunization Practices (ACIP).

P. Strebel, M. Wharton, Peter M. Strebel, 1997 .

Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021

J. Gargano, M. Daley, H. Talbot, 2021, MMWR. Morbidity and mortality weekly report.

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021

J. Gargano, Heather M. Scobie, M. Wharton, 2021, MMWR. Morbidity and mortality weekly report.

Availability and use of hepatitis B vaccine in laboratory and nursing schools in the United States.

S. Roush, C. Shapiro, S. Hadler, 1991, Public health reports.

Hepatitis B vaccination in children: five year booster study.

N. Pearce, S. Krugman, J. Waldon, 1992, The New Zealand medical journal.

Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).

J. P. Davis, C. Broome, S. Reef, 1998, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

Rubella seropositivity in the United States, 1988-1994.

D. Kruszon-Moran, G. Mcquillan, B. Forghani, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Implementing a Multisite Clinical Trial in the Midst of an Ebola Outbreak: Lessons Learned From the Sierra Leone Trial to Introduce a Vaccine Against Ebola

A. Schuchat, S. Schrag, J. Bresee, 2018, The Journal of infectious diseases.

Measles outbreaks in the United States, 1987 through 1990.

L. Markowitz, S. Hutchins, S. Hadler, 1996, The Pediatric infectious disease journal.

General Recommendations on Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP), Morbidity and Mortaility Weekly Report, January 28, 1994. Volume 43, Number RR-1

C. Lebaron, S. Hutchins, S. Hadler, 1994 .

Economic evaluation of use of diphtheria, tetanus, and acellular pertussis vaccine or diphtheria, tetanus, and whole-cell pertussis vaccine in the United States, 1997.

M. Meltzer, D. Ekwueme, P. Strebel, 2000, Archives of pediatrics & adolescent medicine.

Vaccines of importance in the hospital setting. Problems and developments.

P. Reichelderfer, W. Williams, S. Hadler, 1989, Infectious disease clinics of North America.

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

C. Whitney, M. Moore, T. Pilishvili, 2014, MMWR. Morbidity and mortality weekly report.

Hepatitis A Surveillance and Vaccine Use in China From 1990 Through 2007

Hui-hui Zheng, F. Cui, Fu-zhen Wang, 2009, Journal of epidemiology.

Mumps surveillance--United States, 1988-1993.

M. Lindegren, S. Cochi, W. Williams, 1995, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

The immunization data quality audit: verifying the quality and consistency of immunization monitoring systems.

J. Lloyd, M. Birmingham, O. Ronveaux, 2005, Bulletin of the World Health Organization.

Nonresponse to Hepatitis B Vaccine in Homosexual Men

J. Phair, J. Chmiel, D. Ostrow, 1987, Sexually Transmitted Diseases.

Vaccination levels associated with lack of measles transmission among preschool-aged populations in the United States, 1989-1991.

S. Hutchins, S. Hadler, A. Baughman, 2004, The Journal of infectious diseases.

Potential impact on vaccination coverage levels by administering vaccines simultaneously and reducing dropout rates.

E. Zell, V. Dietz, S. Cochi, 1994, Archives of pediatrics & adolescent medicine.

Progress Toward Poliomyelitis Eradication — Afghanistan and Pakistan, January 2013–August 2014

J. Alexander, E. Durry, S. Hadler, 2014, MMWR. Morbidity and mortality weekly report.

Tetanus immunization: Concerns about the elderly and about diphtheria reemergence

B. Littenberg, R. Sutter, S. Katz, 1994, Journal of General Internal Medicine.

Progress Toward Poliomyelitis Eradication — Afghanistan, January 2016–June 2017

J. Jorba, S. Hadler, Hemant Shukla, 2015, MMWR. Morbidity and mortality weekly report.

Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children: an analysis of the Vaccine Safety Datalink (VSD) Project.

John W. Glasser, E. Lewis, R. Davis, 1997, The Pediatric infectious disease journal.

Publication of CDC Surveillance Summaries

S. Redd, W. Orenstein, S. Hadler, 1993 .

Measles Herd Immunity: The Association of Attack Rates With Immunization Rates in Preschool Children

S. Hadler, A. Baughman, T. Schlenker, 1992 .

Respiratory illness caused by Corynebacterium diphtheriae and C. ulcerans, and use of diphtheria anti-toxin in the United States, 1996-2018.

Anna M. Acosta, S. Hariri, T. Tiwari, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Measles herd immunity. The association of attack rates with immunization rates in preschool children.

A L Baughman, S. Hadler, S C Hadler, 1992, JAMA.

National serologic survey of measles immunity among persons 6 years of age or older, 1988-1994.

W. Bellini, D. Kruszon-Moran, G. Mcquillan, 2001, MedGenMed : Medscape general medicine.

Modeling Poliovirus Transmission in Pakistan and Afghanistan to Inform Vaccination Strategies in Undervaccinated Subpopulations

M. Pallansch, K. Thompson, R. D. Duintjer Tebbens, 2018, Risk analysis : an official publication of the Society for Risk Analysis.

Key outcomes and addressing remaining challenges--perspectives from a final evaluation of the China GAVI project.

S. Hadler, Weizhong Yang, Xiaofeng Liang, 2013, Vaccine.

Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.

M. Wharton, S. Reef, W. Williams, 1996, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States.

Robert T. Chen, S. Hadler, P. Rhodes, 1997, American journal of public health.

A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States.

J. Gargano, T. Shimabukuro, K. Broder, 2023, Vaccine.

Polio eradication initiative in Afghanistan, 1997-2013.

S. Shaukat, C. Garrigós, S. Hadler, 2014, The Journal of infectious diseases.

Routine Immunization Service Delivery Through the Basic Package of Health Services Program in Afghanistan: Gaps, Challenges, and Opportunities

S. Hadler, Kimberly A. Porter, C. Mbaeyi, 2017, The Journal of infectious diseases.

Tetanus Immunization in Adults-Reply

M. Wharton, R. Sutter, K. Bisgard, 1994 .